[1] Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29-322.[2] Hou J, Wang L, Jiang J, et al. Cardiac stem cells and their roles in myocardial infarction. Stem Cell Rev. 2013;9(3): 326-338.[3] Xing Y, Hou J, Guo T, et al. microRNA-378 promotes mesenchymal stem cell survival and vascularization under hypoxic-ischemic conditions in vitro. Stem Cell Res Ther. 2014;5(6):130.[4] Hou J, Wang L, Hou J, et al. Peroxisome Proliferator- Activated Receptor Gamma Promotes Mesenchymal Stem Cells to Express Connexin43 via the Inhibition of TGF-β1/Smads Signaling in a Rat Model of Myocardial Infarction. Stem Cell Rev. 2015;11(6):885-899.[5] Park JS, Suryaprakash S, Lao YH, et al. Engineering mesenchymal stem cells for regenerative medicine and drug delivery. Methods. 2015;84:3-16.[6] Dey BK, Mueller AC, Dutta A. Long non-coding RNAs as emerging regulators of differentiation, development, and disease. Transcription. 2014;5(4):e944014.[7] Ounzain S, Crippa S, Pedrazzini T. Small and long non-coding RNAs in cardiac homeostasis and regeneration. Biochim Biophys Acta. 2013;1833(4):923-933.[8] May D, Blow MJ, Kaplan T, et al. Large-scale discovery of enhancers from human heart tissue. Nat Genet. 2011;44(1): 89-93.[9] Ounzain S, Pedrazzini T. The promise of enhancer- associated long noncoding RNAs in cardiac regeneration. Trends Cardiovasc Med. 2015;25(7):592-602.[10] Wamstad JA, Alexander JM, Truty RM, et al. Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell. 2012;151(1):206-220.[11] Dey BK, Mueller AC, Dutta A. Long non-coding RNAs as emerging regulators of differentiation, development, and disease. Transcription. 2014;5(4):e944014.[12] Klattenhoff CA, Scheuermann JC, Surface LE, et al. Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell. 2013;152(3):570-583.[13] Xue Z, Hennelly S, Doyle B, et al. A G-Rich Motif in the lncRNA Braveheart Interacts with a Zinc-Finger Transcription Factor to Specify the Cardiovascular Lineage. Mol Cell. 2016; 64(1):37-50.[14] 侯婧瑛,汪蕾,钟婷婷,等. apelin干预骨髓间充质干细胞在缺血缺氧条件下的生存和血管再生[J].中国组织工程研究, 2017,21(1): 6-12.[15] Hou J, Zhong T, Guo T, et al. Apelin promotes mesenchymal stem cells survival and vascularization under hypoxic-ischemic condition in vitro involving the upregulation of vascular endothelial growth factor. Exp Mol Pathol. 2017; 102(2):203-209.[16] Gao Q, Guo M, Jiang X, et al. A cocktail method for promoting cardiomyocyte differentiation from bone marrow-derived mesenchymal stem cells. Stem Cells Int. 2014;2014:162024.[17] Supokawej A, Kheolamai P, Nartprayut K, et al. Cardiogenic and myogenic gene expression in mesenchymal stem cells after 5-azacytidine treatment. Turk J Haematol. 2013;30(2): 115-121. [18] Rinn J, Guttman M. RNA Function. RNA and dynamic nuclear organization. Science. 2014;345(6202):1240-1241.[19] Rosa A, Ballarino M. Long Noncoding RNA Regulation of Pluripotency. Stem Cells Int. 2016;2016:1797692.[20] Fujimori H, Mukai H, Murakami Y, et al. The H19 induction triggers trophoblast lineage commitment in mouse ES cells. Biochem Biophys Res Commun. 2013;436(2):313-318.[21] Dey BK, Pfeifer K, Dutta A. The H19 long noncoding RNA gives rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle differentiation and regeneration. Genes Dev. 2014;28(5):491-501.[22] Ohnuki M, Tanabe K, Sutou K, et al. Dynamic regulation of human endogenous retroviruses mediates factor-induced reprogramming and differentiation potential. Proc Natl Acad Sci U S A. 2014;111(34):12426-12431.[23] Watts R, Johnsen VL, Shearer J, et al. Myostatin-induced inhibition of the long noncoding RNA Malat1 is associated with decreased myogenesis. Am J Physiol Cell Physiol. 2013;304(10):C995-1001.[24] Zuo C, Wang Z, Lu H, et al. Expression profiling of lncRNAs in C3H10T1/2 mesenchymal stem cells undergoing early osteoblast differentiation. Mol Med Rep. 2013;8(2):463-467.[25] Ounzain S, Pezzuto I, Micheletti R, et al. Functional importance of cardiac enhancer-associated noncoding RNAs in heart development and disease. J Mol Cell Cardiol. 2014; 76:55-70.[26] Ragina NP, Schlosser K, Knott JG, et al. Downregulation of H19 improves the differentiation potential of mouse parthenogenetic embryonic stem cells. Stem Cells Dev. 2012;21(7):1134-1144.[27] Ounzain S, Micheletti R, Arnan C, et al. CARMEN, a human super enhancer-associated long noncoding RNA controlling cardiac specification, differentiation and homeostasis. J Mol Cell Cardiol. 2015;89(Pt A):98-112.[28] Kurian L, Aguirre A, Sancho-Martinez I, et al. Identification of novel long noncoding RNAs underlying vertebrate cardiovascular development. Circulation. 2015;131(14): 1278-1290.[29] Zangrando J, Zhang L, Vausort M, et al. Identification of candidate long non-coding RNAs in response to myocardial infarction. BMC Genomics. 2014;15:460.[30] Liao J, He Q, Li M, et al. LncRNA MIAT: Myocardial infarction associated and more. Gene. 2016;578(2):158-161. |